Cargando…
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India
POSTER SESSION 1, SEPTEMBER 21, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: This study aimed primarily to determine the etiology, clinical features, and comorbidities of patients with rhino-orbito-cerebral mycosis. Secondly, antifungal susceptibility pattern of the isolates and lineage by ITS-sequencing...
Autores principales: | Taneja, Juhi, Chatterjee, Kuhu, Sasidharan, Jaseetha, Abbas, Zafar, Rai, Anil K, Das, Bhabatosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494483/ http://dx.doi.org/10.1093/mmy/myac072.P086 |
Ejemplares similares
-
P265 Phaeohyphomycosis caused by Rhinocladiella similis mimicking Sporotrichosis
por: Taneja, Juhi, et al.
Publicado: (2022) -
Rhino-Orbito-Cerebral Mycosis and COVID-19: From Bad to Worse?
por: Kulkarni, Rahul, et al.
Publicado: (2022) -
Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis
por: Chatterjee, Kuhu, et al.
Publicado: (2022) -
Rhino-orbito-cerebral mucormycosis
por: Raymundo, Igor Teixeira, et al.
Publicado: (2015) -
Correction to: Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis
por: Chatterjee, Kuhu, et al.
Publicado: (2022)